Diabetes, TZDs, and bone: A review of the clinical evidence

PPAR Research

Volumn , Issue , 2006, Pages

  Schwartz, Ann V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42749101870     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/PPAR/2006/24502     Document Type: Review

References (47)

1. S O Rzonca L J Suva D Gaddy D C Montague B Lecka-Czernik BLecka-Czernik@uams.edu Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 145 1 2004 401 406
2. M A Sorocéanu D Miao X-Y Bai H Su D Goltzman A C Karaplis akarapli@ldi.jgh.mcgill.ca Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis. Journal of Endocrinology 183 1 2004 203 216
3. V Sottile K Seuwen klaus.seuwen@pharma.novartis.com M Kneissel michaela.kneissel@pharma.novartis.com Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone). Calcified Tissue International 75 4 2004 329 337
4. C Jennermann J Triantafillou D Cowan B Pennink K Connolly D Morris Effects of thiazolidinediones on bone turnover in the rat. Journal of Bone and Mineral Research 10 1995 S241 (Abstract S361)
5. L Tornvig L Mosekilde J Justesen E Falk M Kassem Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice. Calcified Tissue International 69 1 2001 46 50
6. H III Heath L J III Melton C P Chu Diabetes mellitus and risk of skeletal fracture. New England Journal of Medicine 303 10 1980 567 570
7. H E Meyer A Tverdal J A Falch Risk factors for hip fracture in middle-aged Norwegian women and men. American Journal of Epidemiology 137 11 1993 1203 1211
8. L Forsén H E Meyer K Midthjell T-H Edna Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 42 8 1999 920 925
9. A V Schwartz D E Sellmeyer K E Ensrud Older women with diabetes have an increased risk of fracture: a prospective study. Journal of Clinical Endocrinology and Metabolism 86 1 2001 32 38
10. K K Nicodemus A R Folsom folsom@epi.umn.edu Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 24 7 2001 1192 1197
11. K J Ottenbacher G V Ostir M K Peek J S Goodwin K S Markides Diabetes mellitus as a risk factor for hip fracture in Mexican American older adults. Journals of Gerontology - Series A Biological Sciences and Medical Sciences 57 10 2002 M648 M653
12. L A Ahmed Luai.Awad@ism.uit.no R M Joakimsen G K Berntsen V Fønnebø H Schirmer Diabetes mellitus and the risk of non-vertebral fractures: the Tromsø study. Osteoporosis International 17 4 2006 495 500
13. I I De Liefde M Van Der Klift marjoleinvdklift@hotmail.com C EDH De Laet P LA Van Daele A Hofman H AP Pols Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporosis International 16 12 2005 1713 1720
14. A H Holmberg Anna.Holmberg@skane.se O Johnell P M Nilsson J-Å Nilsson G Berglund K Åkesson Risk factors for hip fractures in a middle-aged population: a study of 33,000 men and women. Osteoporosis International 16 12 2005 2185 2194
15. T HM Keegan J L Kelsey S Sidney C P Jr Quesenberry Foot problems as risk factors of fractures. American Journal of Epidemiology 155 10 2002 926 931
16. E S Strotmeyer J A Cauley A V Schwartz Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Archives of Internal Medicine 165 14 2005 1612 1617
17. D A Hanley dahanley@ucalgary.ca J P Brown A Tenenhouse Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. Journal of Bone and Mineral Research 18 4 2003 784 790
18. K E Ensrud D E Thompson J A Cauley Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. Journal of the American Geriatrics Society 48 3 2000 241 249 [see comments]
19. D C Bauer W S Browner J A Cauley Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Annals of Internal Medicine 118 9 1993 657 665
20. E Barrett-Connor T L Holbrook Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. Journal of the American Medical Association 268 23 1992 3333 3337
21. P LA Van Daele R P Stolk H Burger Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Annals of Internal Medicine 122 6 1995 409 414
22. J Verhaeghe A MH Suiker T A Einhorn Brittle bones in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: studies in diabetic and ovariectomized rats. Journal of Bone and Mineral Research 9 10 1994 1657 1667
23. A V Schwartz aschwartz@psg.ucsf.edu D E Sellmeyer E S Strotmeyer Diabetes and bone loss at the hip in older black and white adults. Journal of Bone and Mineral Research 20 4 2005 596 603
24. M T Hannan D T Felson B Dawson-Hughes Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. Journal of Bone and Mineral Research 15 4 2000 710 720
25. T A Ricci S B Heymsfield R N Jr Pierson T Stahl H A Chowdhury S A Shapses Moderate energy restriction increases bone resorption in obese postmenopausal women. American Journal of Clinical Nutrition 73 2 2001 347 352
26. H C Looker hlooker@mail.nih.gov W C Knowler R L Hanson Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care 24 11 2001 1917 1922
27. A V Schwartz aschwartz@psg.ucsf.edu T A Hillier D E Sellmeyer Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 25 10 2002 1749 1754
28. E W Gregg edg7@cdc.gov C M Mangione J A Cauley Diabetes and incidence of functional disability in older women. Diabetes Care 25 1 2002 61 67
29. D K Miller millerdk@slu.edu L-Y L Lui H M III Perry F E Kaiser J E Morley Reported and measured physical functioning in older inner-city diabetic African Americans. Journals of Gerontology - Series A Biological Sciences and Medical Sciences 54 5 1999 M230 M236
30. J T Hanlon L R Landerman G G Fillenbaum S Studenski Falls in African American and white community-dwelling elderly residents. Journals of Gerontology - Series A Biological Sciences and Medical Sciences 57 7 2002 M473 M478
31. A V Schwartz aschwartz@psg.ucsf.edu Diabetes mellitus: does it affect bone? Calcified Tissue International 73 6 2003 515 519
32. L Mascitelli lumasci@libero.it F Pezzetta Thiazolidinediones and the risk of nontraumatic fractures in patients with diabetes. Archives of Internal Medicine 166 1 2006 126
33. D K Wysowski wysowski@cder.fda.gov G Armstrong L Governale Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001. Diabetes Care 26 6 2003 1852 1855
34. B Lecka-Czernik bxczernik@life.uams.edu I Gubrij E J Moerman Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARγ2. Journal of Cellular Biochemistry 74 3 1999 357 371
35. S M Jackson smjack@ucla.edu L L Demer Peroxisome proliferator-activated receptor activators modulate the osteoblastic maturation of MC3T3-E1 preosteoblasts. FEBS Letters 471 1 2000 119 124
36. B Lecka-Czernik E J Moerman D F Grant J M Lehmann S C Manolagas R L Jilka Divergent effects of selective peroxisome proliferator-activated receptor-γ2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 143 6 2002 2376 2384
37. O P Lazarenko S O Rzonca L J Suva B Lecka-Czernik leckaczernikbeata@uams. edu Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat. Bone 38 1 2006 74 84
38. M E Nuttall Mark_E_Nuttall@SBPHRD.COM A J Patton D L Olivera D P Nadeau M Gowen Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. Journal of Bone and Mineral Research 13 3 1998 371 382
39. R Okazaki M Miura M Toriumi Short-term treatment with troglitazone decreases bone turnover in patients with type 2 diabetes mellitus. Endocrine Journal 46 6 1999 795 801
40. R Okazaki Y Totsuka K Hamano Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. Journal of Clinical Endocrinology and Metabolism 82 9 1997 2915 2920
41. S Watanabe Y Takeuchi S Fukumoto H Fujita T Nakano T Fujita Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients. Journal of Bone and Mineral Metabolism 21 3 2003 166 171
42. A V Schwartz D E Sellmeyer E Vittinghoff Thiazolidinedione (TZD) use and bone loss in older diabetic adults. Journal of Clinical Endocrinology and Metabolism 91 9 2006 3349 3354
43. A M Schott C Cormier D Hans How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS Prospective Study. Osteoporosis International 8 3 1998 247 254
44. H H Bolotin H Sievänen Inaccuracies inherent in dual-energy X-ray absorptiometry in vivo bone mineral density can seriously mislead diagnostic/prognostic interpretations of patient-specific bone fragility. Journal of Bone and Mineral Research 16 5 2001 799 805
45. H H Bolotin herb.bolotin@rmit.edu.au H Sievänen J L Grashuis Patient-specific DXA bone mineral density inaccuracies: quantitative effects of nonuniform extraosseous fat distributions. Journal of Bone and Mineral Research 18 6 2003 1020 1027
46. P Tothill peter.tothill@ed.ac.uk Dual-energy X-ray absorptiometry measurements of total-body bone mineral during weight change. Journal of Clinical Densitometry 8 1 2005 31 38
47. D Chappard daniel.chappard@univ-angers.fr M Moquereau P Mercier Ex vivo bone mineral density of the wrist: influence of medullar fat. Bone 34 6 2004 1023 1028